Jenna Gregory’s research focuses on the molecular mechanisms underlying neurodegenerative diseases with a particular focus on ALS. Her work involves studying patient post-mortem material for molecular differences that could explain why people with ALS have such diverse symptoms, including differences in disease progression and cognitive involvement. The aim of her work is to identify targets that could be used for diagnosis or to monitor disease progression, or ultimately, for therapies to improve the outlook for people with ALS.